|
Age, in years
|
35.29 ± 14.70
|
32(15-85)
|
|
Gender
| | |
|
Female
|
155
|
29.1%
|
|
Male
|
377
|
70.9%
|
|
Length of hospital stay
|
3.46 ± 3.45
|
3(1-33 days); 3[2-4]
|
|
Peak creatinine (μmole/litre)
|
98.124 ± 83.98
|
79.56(17.68-875.16)
|
|
Peak creatinine in AKI (μmole/litre)
|
229.84 ± 174.15
|
149.6(114.92-875.16)
|
|
Admission creatinine (μmole/litre)
|
90.16 ± 61.88
|
79.56(17.68-857.48)
|
|
Admission hematocrit (Proportion of 1.0)
|
0.4102 ± 0.063
|
0.415(0.199-0.58)
|
|
Peak hematocrit (Proportion of 1.0)
|
0.422 ± 0.0563
|
0.424(0.264-0.58)
|
|
Platelets
|
38.65 ± 42.14
|
23(2-427)
|
|
Alanine aminotransferase (μkat/L)
|
2.73 ± 5.86
|
1.27(0.050-60.55)
|
|
Prothrombin time (Seconds)
|
12.82 ± 8.70
|
11.10(3-120)
|
|
aPTT (Seconds)
|
36.02 ± 15.12
|
33.35(11.2-120)
|
|
Vasopressin
|
5
|
0.9%
|
|
Central nervous system involvement
|
11
|
2.1%
|
|
Respiratory failure
|
14
|
2.6%
|
|
World Health Organization Classification
| | |
|
Dengue fever
|
449
|
84.4%
|
|
Dengue hemorrhagic fever
|
76
|
14.3%
|
|
Dengue shock syndrome
|
7
|
1.3%
|
|
Length of stay in hospital
| | |
|
≤3 days
|
386
|
72.6%
|
|
>3 days
|
146
|
27.4%
|
|
Alanine aminotransferase
| | |
|
Normal
|
156
|
29.3%
|
|
Mild hepatitis 0.75 - 5.01 μkat/L
|
329
|
61.8%
|
|
Severe hepatitis >5.01 μkat/L
|
47
|
8.8%
|
|
Prothrombin time (Seconds)
| | |
|
≤15
|
468
|
88%
|
|
>15
|
64
|
12%
|
|
Activated partial thromboplastin time (Seconds)
| | |
|
≤ 35
|
307
|
57.7%
|
|
>35
|
225
|
42.3%
|
|
Platelets (Micro/liter)
| | |
|
<50000
|
406
|
76.3%
|
|
50000-100000
|
93
|
17.5%
|
|
100000-150000
|
23
|
4.3%
|
|
>150000
|
10
|
1.9%
|
|
Number of dengue cases/years
| | |
|
2008
|
76
|
14.3%
|
|
2009
|
148
|
27.8%
|
|
2010
|
308
|
57.9%
|
